Saturday, November 2, 2024
HomeTagsBiosimilarity

biosimilarity

Stimufend Now Available in the United States

Fresenius Kabi announced the immediate availability in the U.S. of Stimufend, the company’s biosimilar to Neulasta, for use in patients at risk for febrile...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics